We report here the molecular cloning and characterization of a t(1;14)(q21;q32) in a follicular lymphoma (FL) with an unusual BCL2 aberration. Fluorescence in situ hybridization (FISH) and Southern blot analysis of tumor cells identi®ed the translocation breakpoint within the 5' switch region of IGHG (Sg). We cloned the chimeric breakpoint region approximately 1.5 kbp downstream from the HindIII site of 5'Sg2 on chromosome 14q32 and identi®ed a 360-bp novel segment with homology to the CpG island clone 11h8. Two BAC clones containing this sequence were isolated and mapped to 1q21 by FISH. BAC 342/P13 contained sequences homologous to Fcg receptors 2A, 3A, 2B, 3B, and a heat shock protein gene HSP70B. The translocation brought the Sg2 region of a productive IGH allele 20*30 kbp upstream of FCGR2B. As a result of the translocation, the b2 isoform of FCGR2B was overexpressed in the tumor. Screening of a panel of 76 B-cell lymphomas with 1q21-23 cytogenetic aberrations by Southern blot analysis using breakpoint probes identi®ed an additional FL with a t(14;18)(q32;q21) and a breakpoint in the FCGR2B region. These results suggest that FCGR2B may be deregulated by 1q21 aberration in BCL2 rearranged FLs and possibly play a role in their progression. Oncogene (2001) 20, 7686 ± 7693.
Introduction
Non-random chromosomal translocations characterize the majority of non-Hodgkin's lymphomas (NHL) . They frequently target the IG loci, correlate with histologic subsets, and lead to deregulation of genes that control B-cell proliferation, dierentiation, and apoptosis Willis and Dyer, 2000; Dalla-Favera et al., 1999) . The molecular basis of this deregulation consists of potent enhancer eects by elements in the IG loci and/or promoter substitution (Dalla-Favera et al., 1999) .
Rearrangements aecting the 1q21-23 region are the third most common chromosomal alterations in B-cell NHL . Abnormalities aecting the 1q21-23 region are considered to be secondary genetic changes since they usually occur in association with other aberrations considered to be primary, such as t(8;14)(q24;q32) and t(14;18)(q32;q21) . In addition, multiple studies have shown 1q21-23 aberrations to be associated with poor prognosis (Tilly et al., 1994; Ot et al., 1991) . The instability at this chromosomal site in NHL appears to be complex with heterogeneous molecular breaks (Cigudosa et al., 1999) . A subset of the reciprocal translocations aecting this region involves the IG gene sites, and molecular genetic analysis of such translocations so far identi®ed four breakpoint clusters involving BCL9 in acute lymphoblastic leukemia (ALL) (Willis et al., 1998) , FCGR2B in FL (Callanan et al., 2000) , MUC1 in diuse large cell lymphoma (DLCL) (Dyomin et al., 2000) , and IRTA1/IRTA2 in multiple myeloma (MM) (Hatzivassiliou et al., 2001) . Rearrangements aecting these genes account for 5 to 10% of cases of B-cell NHL (Willis et al., 1998; Callanan et al., 2000 , Dyomin et al., 2000 Hatzivassiliou et al., 2001 ). Here we report the molecular cloning of a t(1;14)(q21;q32) in a FL and identify the translocation breakpoint 20*30-kbp telomeric of FCGR3B and 5-kbp centromeric of FCGR2B at 1q21-22. Overexpression of the b2 isoform of FCGR2B (FCGR2B-b2) was observed in this case suggesting that FCGR2B is the target gene deregulated by this translocation. Screening of a large panel of B-cell lymphomas with 1q21-23 cytogenetic aberrations by Southern blot analysis using probes¯anking the breakpoint in the index case identi®ed an additional FL with a dup(1)(q21q25) and a DNA rearrangement in the FCGR2B region. Both cases also exhibited aberrations involving 14q32 and 18q21. A previous study reported three cases of FLs with t(14;18)(q32;q21) and t(1;22)(q21;q11) and breaks in the vicinity of FCGR2B as well as up-regulated FCGR2B-b2 in two of the three cases which were analysed (Callanan et al., 2000) . FCGR2B is a member of the Fc receptor gene family known to be involved in mediation of immune response and apoptosis. These data indicate that FCGR2B deregulation by chromosomal rearrangement characterizes a subset of FL with BCL2 aberration and may represent a secondary abnormality, possibly associated with tumor progression.
Results

FISH analysis of the translocation breakpoint
FISH analysis of tumor metaphases was performed to map the chromosomes 1 and 14 translocation breakpoints in tumor 2173 in relation to the previously identi®ed 1q21 breakpoints in lymphoma translocations aecting BCL9, MUC1, and IRTA1/IRTA2 genes. PAC clones 288D9 and 35A12, as well as YAC clone 748F9 were all retained on the der(1) chromosome indicating that the breakpoint was distal to these genes (data not shown). The breakpoint in chromosome 14 was assessed using the IGH probes. The plasmid containing the BamHI ± HindIII JH fragment hybridized to the der(1) chromosome, indicating that the breakpoint was proximal to the IGHJ gene. No signal was detected with this probe on the normal-appearing chromosome 14, suggesting a deletion in the IGH locus in this allele ( Figure 1A ). The Ca1 probe hybridized to the der(1) and der(14) chromosomes as well as the normal appearing chromosome 14 ( Figure 1B) . Ca1 cross hybridizes to Ca2 due to the high homology between the two genes. Thus, the hybridization pattern noted indicated that the breakpoint in the der(14) chromosome occurred in an approximately 150-kbp region between Ca1 and Ca2, with Ca1 translocating to the der(1) and Ca2 retained on the der(14) chromosome. The Cg4 signal was detected on the normal-appearing chromosome 14 and the der(1) chromosome, but not on the der(14) chromosome ( Figure 1C) . Absence of Cg4 signal on der(14) suggested that the breakpoint was near or downstream of Cg4.
Southern blot analysis of IGH rearrangement
Southern blot analysis of tumor 2173 DNA detected two BamHI-rearranged bands (11-kbp and 10-kbp) in comparison to normal placenta with the JH probe ( Figure 2A ). The 11-kbp rearranged band co-hybridized with the Cm probe, representing a productive VDJ rearrangement in the tumor (data not shown). The 10-kbp rearranged band was not recognized by any of the constant region probes and therefore probably represented an internal rearrangement in the IGHJ region of the normal appearing chromosome 14. The ®lter was then sequentially hybridized with 5'Sg and 3'Sg probes to detect a Sg-rearranged allele that did not co-hybridize to these probes. A band displaying such a hybridization pattern in B-cell lymphoma DNA has previously been shown to indicate an illegitimate Sg rearrangement that was usually derived from a chromosomal translocation (Bergsagel et al., 1996) . In tumor 2173, the 5'Sg probe detected a 1.8-kbp HindIIIand a 5-kbp BglII-rearranged fragment that were not detected by the 3'Sg probe, indicating an 1q21-associated translocation breakpoint ( Figure 2B ,C). These data are consistent with the FISH results discussed above. The 10-kbp BamHI-rearranged fragment detected by the JH probe was cloned from a genomic library of the tumor. Restriction enzyme mapping and partial sequencing of the clone revealed an unusual BCL2 aberration, comprising a 3-kbp fragment with exons 1 and 2 of BCL2 located 5' of the JH region in a head-to-head orientation ( Figure 3A ). In addition, the 3' end of the clone contained an intrachromosomal breakpoint linking the IGHM enhancer (Em) sequences to an Ig3 region ( Figure 3A) ; thus, in this allele, the entire Cm region was deleted and a region of chromosome 18 containing BCL2 was inserted. For further con®rmation of this insertion, 2-color FISH analysis of tumor metaphases was performed using the BCL2-containing PAC 408B18 and the JH phage (F1422). PAC 408B18 hybridized to one normal chromosome 18 and the normal-appearing chromosome 14, with no signal apparent on the remaining chromosome 18. The JH phage hybridized to the der(1) chromosome and the normal-appearing chromosome 14 ( Figure 3B ). The colocalization of the PAC and the phage signals on the normal-appearing chromosome 14 con®rmed the results of the cloning described above. Hybridization with the chromosome 14 sub-telomeric PAC (120H10) showed that the IGHV region was retained in the normalappearing as well as the der (14) chromosomes ( Figure  3C ), further con®rming the insertion of BCL2 into the IGHJ region of the normal-appearing chromosome 14. The 3' breakpoint of BCL2 could not be identi®ed; neither an mbr nor an mcr rearrangement was detected by Southern blot analysis (data not shown). In addition, sequence analysis of the 1-kbp BCL2 fragment near the BCL2/IGHJ breakpoint junction identi®ed 10 point mutations in the non-coding region of exon 1 from position 357 to position 507 (GenBank Accession # M13994). Deletion of Cm in the normal-appearing chromosome 14 suggested that the IGHM gene in the der(1) chromosome was the productive allele.
Cloning of the t(1;14)(q21;q32) translocation breakpoint
Results of the FISH and Southern blot analysis described above indicated the presence of a 1q21-associated breakpoint within a Sg region. The 1.8-kbp HindIII-rearranged fragment identi®ed by 5'Sg probe in Southern blot analysis was cloned by inverse PCR using two pairs of 5'Sg-speci®c primers ( Figure 2B ). The PCR yielded a 1.2-kbp fragment from the tumor exclusive of the 600-bp hairpins. Sequence analysis of the fragment showed that a 360-bp non-IGH sequence with homology to the CpG island clone 11h8 (GenBank Accession # Z64452) was joined downstream of 5'Sg ( Figure 4A ). Hybridization of this sequence (X360) to a somatic cell hybrid DNA panel in Southern blot analysis con®rmed its derivation from chromosome 1 (data not shown). When the X360 probe was hybridized to the tumor DNA, it also identi®ed the initial rearrangement detected by the 5' Sg probe con®rming the isolation of the translocation junction (data not shown). The X360 probe was then used to screen a human BAC library. Two BAC clones (342/P13 and 304/N2) were obtained for further analysis of the translocation breakpoint and identi®ca-tion of potential target gene(s). By partial sequencing (Callanan et al., 2000) . The known normal orientations of the Fc receptor genes are shown below the genes. The alteration of the FCGR3B orientation is shown by the gray arrow. The vertical arrow indicates the breakpoint. A BAC clone (342/p13) and two plasmid clones derived from the BAC and used for probes are shown (B).
FCGR2B deregulation in follicular lymphoma
W Chen et al of 10 plasmid clones derived from BAC 342/P13, sequences homologous to the immunoglobulin Fc receptor genes FCGR2A, FCGR3A, FCGR2B, FCGR3B, and the heat shock protein gene HSP70B were identi®ed. In addition, a sequence homologous to the fragment X360 was found near one end of the plasmid clone, BW9. By restriction enzyme mapping of the breakpoint region in the BAC, another plasmid clone (BW5) was identi®ed adjacent to BW9 near the X360-containing end ( Figure 4B ). Sequencing of BW5 identi®ed the last two exons of FCGR3B (exons 4 and 5). Thus, the breakpoint was mapped 5 kbp downstream of the FCGR3B gene. Based on the previously published genomic organization of the Fcg receptor locus (Qiu et al., 1990) . FCGR2B was assumed to be located approximately 20*30 kbp centromeric to the breakpoint. Thus, the t(1;14)(q21;q32) in this case juxtaposed the 5' switch region of IGHG2 to a region upstream of FCGR2B in the der(1) chromosome.
Deregulation of FCGR2B expression in case 2173
To investigate the functional consequence of the chromosomal translocation on the expression of genes within the low anity Fcg receptor region, RT ± PCR analysis was performed using primer sets containing the FCGR2A/FCGR2C, FCGR2B, and FCGR3B genes ( Figure 5D ), and the heat shock protein gene, HSP70B. FCGR2A, FCGR2B, and FCGR2C genes share high homology in their extracellular and transmembrane regions, while the intracytoplasmic region can distinguish between the members. In addition, diverse receptor isoforms (a1-a3; b1-b3; c1-c4) can be co-expressed in B-cells as a consequence of alternative splicing (Brooks et al., 1989) . In normal active B-cells, FCGR2B-b1 shows higher abundance compared to FCGR2B-b2 (Daeron, 1997) . However, in tumor 2173, FCGR2B speci®c RT ± PCR displayed an increase in the abundance of FCGR2B-b2 relative to that of FCGR2B-b1, compared to 2 BL cell lines ( Figure 5A ). To further investigate the association of the higher abundance of FCGR2B-b2 with the translocation, we assayed 24 FLs from the panel of 76 NHLs-lymphomas and the 8 NHL cell lines for FCGR2B-b2 expression by RT ± PCR. All the FLs and the cell line ISO-Ly17 exhibited a 1q21 cytogenetic abnormality but no FCGR2B/3B rearrangement by Southern blot analysis (data not shown). In addition, 13/23 FLs and 4/8 cell lines carried a t(14;18)(q32;q21). These cases and cell lines expressed low to moderate expression of FCGR2B-b2, with higher abundance of FCGR2B-b1 compared to FCGR2B-b2 ( Figure 5B ,C). FCGR2B expression was absent in two T-cell lymphoma cell lines (OSI-Ly12 and OSI-Ly13). No alteration in the expression of FCGR2A/FCGR2C, FCGR3B and HSP70B was noted in tumor 2173 (data not shown).
The over-expression of FCGR2B-b2 in 2173 suggested FCGR2B to be the target gene deregulated by t(1;14)(q21;q32) in agreement with a previous report of two cases with t(1;22)(q21;q11) (Callanan et al., 2000) . FcgR2B protein expression was not investigated in tumor 2173 due to lack of frozen tumor tissue. Sequence analysis of an 0.8-kbp FCGR2B-b2 RT ± PCR product obtained from this tumor containing the extra-membrane, transmembrane, or intracytoplasmic regions, did not reveal a mutation, suggesting that deregulation of expression of FCGR2B expression was the main consequence of the t(1;14)(q21;q32).
Incidence of FCGR2B rearrangements in 1q21 chromosomal abnormalities in NHL
To determine the incidence of DNA rearrangements involving the FCGR2B/FCGR3B region, the panel of 76 NHL cases was subjected to Southern blot analysis using the X360 and BW5 probes. Among these, only one additional case, tumor 1389, a FL with a dup(1)(1q21-25) and a t(14;18)(q32;q21), showed a BamHI rearrangement in the FCGR2B/FCGR3B region ( Figure 6A ,B). These data, together with those of the previously reported FLs with t(14;18)(q32;q21) and t(1;22)(q21;q11) (Callanan et al., 2000) , suggest that breakpoints aecting the FCGR2B/FCGR3B region may occur in a small subset of FLs carrying BCL2 rearrangements. Unfortunately, frozen tumor tissue suitable for RT ± PCR or Western blot analysis of FCGR2B expression was unavailable for tumor 1389.
Discussion
We report here the cloning and characterization of a chromosomal breakpoint associated with t(1;14)(q21;q32) in a case of FL. The translocation juxtaposed a 5' Sg2 sequence upstream of the FCGR2B, 20*30 kbp telomeric to FCGR2B and 5-kbp centromeric to FCGR3B. A similar breakpoint was recently reported in three FLs with t(1;22)(q21;q11), which mapped 20 kbp telomeric to FCGR2B and upstream of the FCGR3B promoter region (Callanan et al., 2000) . Thus, the breakpoint in tumor 2173 was downstream of FCGR3B, in relation to its transcriptional orientation. This is in contrast to the previously reported breakpoint in t(1;22)(q21;q11), which was upstream of its transcriptional orientation (Callanan et al., 2000) . This discrepancy may be due to an inversion of the FCGR3B region near the breakpoint in tumor 2173.
In vertebrates, the immune response is modulated by a coupling of activation and inhibitory pathways, initiated by immunoreceptors (Daeron, 1997; Ravetch et al., 2000) . Such receptors comprise two broad groups, those containing an immunoreceptor tyrosinebased activation motif (ITAM) (e.g. BCR, TCR, and FcRs for IgG and IgE), and those containing a consensus inhibitory motif (ITIM) of I/LxYxxL (e.g. FcgR2B, CD22, and PIR-B) (Daeron, 1997; Ravetch and Lanier, 2000) . Upon activation, subtypes within these groups can co-engage and the ®nal cellular outcome (calcium mobilization, proliferation, apoptosis) is determined by a balance between the stimulatory and inhibitory signals. FcgR2B is a low anity ITIMcontaining receptor that recognizes the Fc portion of an IgG, the only IgG-FcR found on B-cells (Daeron, 1997) . It has been mapped, along with other Fc receptor genes, to a 200-kbp region in 1q22 with the order: cen?FCGR2A?FCGR3A?FCGR2B?FCGR-3B?FCGR2C?tel (Qiu et al., 1990) . Based on a high degree of sequence redundancy and DNA homology, it has been suggested that these genes have arisen through gene duplication. There are two isoforms of FCGR2B mRNA (b1 and b2) which are derived from alternative splicing and are structurally identical except for the presence of a 19 amino acid insertion in the cytoplasmic tail of the b1 isoform (Daeron, 1997) .
Activation of B-cells through BCR can be abrogated by co-ligation of FcgR2B. Crucial to the inhibitory mechanism, is the phosphorylation of the tyrosine in the ITIM of FcgR2B by an ITAM-associated tyrosine kinase (e.g. Lyn kinase), followed by recruitment of an SH2-containing inositol phosphatase (SHIP), and leading ultimately to an inhibition of calcium in¯ux and cellular proliferation. In the former case, SHIP hydrolyzes phosphatidylinositol triphosphate with subsequent dissociation of Bruton's tyrosine kinase (Btk) and PLCg, thus preventing calcium in¯ux which is needed for such processes as phagocytosis and cytokine release (Ono et al., 1996; Bolland et al., 1998) . The precise role of SHIP recruitment in abrogation of B-cell proliferation is as yet unclear, however, inactivation of MAP kinases, through activation of the adaptor protein Dok, may be important in this inhibitory pathway (Tamir et al., 2000; Yamanishi et al., 2000) . It has also been reported that upon homoaggregation of Fcg2B, a proapoptotic pathway is activated, independent of the ITIM but requiring an intact transmembrane domain (Pearse et al., 1999) . This pathway is thought to be a stress-induced response, which can be rescued by SHIP recruitment (Pearse et al., 1999) . Thus, FcgR2B in addition to mediation of the immune response (through ITIM), can function as an inducer of an apoptotic signal when a B-cell perceives a stress signal. So far, this immunoreceptor has not been associated with a proliferative response.
As shown here, in a subset of FL with 1q21-associated chromosomal translocations the b2 isoform of FcgR2B is over-expressed relative to the b1 isoform. Few functional dierences have been reported between the two isoforms. Resting and activated B-cells express FcgR2Bb1 and FcgR2Bb2 at dierent proportions, with an accumulation of the b1 isoform upon mlgM cross-linking, IL-4, or phorbolester (Sarmay et al., 1995) . In vivo studies indicated that upon human B cell activation and BCR-coligation, only Fcg2Bb1 is tyrosine phosphorylated (most likely by Lyn kinase) and not the b2 isoform (Budde et al., 1994) . While the precise signi®cance of selective up-regulation of the b2 isoform in the 1q21-associated translocation is unclear, it is possible that alteration in the b2/b1 ratio in B-cells may promote B cell survival, since phosphorylation of Fcg2B is crucial to its inhibitory function. Thus, in such a system that is modulated by both activating and inhibitory signals, it is conceivable that over-expression of the b2 isoform leads to an inappropriate cellular proliferative response. Alternatively, under immunologic stress, homoaggregation of over-expressed FcgR2B may lead to excess recruitment of SHIP, leading to a rescue, rather than to an apoptotic signal. Since overexpression of FcgR2Bb2 occurs in FL as an additional abnormality in the context of BCL2 deregulation, such hypotheses can be tested in transgenic mice overexpressing BCL2 and FCGR2B (b1 and b2 isoforms). Of interest in this context, FCGR2B has been shown to be a tumor-enhancing factor in non-lymphoid cells in a murine in vivo and in vivo model (Zusman et al., 1996; Witz and Rhan, 1992) . In this study, two cases of FL with BCL2 aberrations and 1q21 rearrangements with a breakpoint within the FCGR2B/FCGR3B locus were identi®ed. These data, together with the previously published cases of FL with t(14;18)(q32;q21) and t(1;22)(q21;q11) (Callanan et al., 2000) , suggest that FCGR2B deregulation may be a feature of a subset of FLs with BCL2 deregulation, both brought about by chromosomal rearrangement. The BCL2 insertion in case 2173 aected the non-productive IGHJ allele, while the t(1;14)(q21;q32) breakpoint was in the IGHG switch region of the productive allele, suggesting that the former occurred during VDJ recombination and the latter during IGH switch recombination associated with germinal center maturation of the B-cells. Deregulation of FCGR2B expression may thus comprise a secondary genetic event, which may impart additional growth advantage to the BCL2-deregulated B-cells. Such a view is consistent with the reported association of 1q21 abnormality with tumor progression (Ot et al., 1991) . Both cases with FCGR2B rearrangement studied here showed evidence of histological transformation from FL to DLCL.
Materials and methods
Tumor ascertainment and cytogenetics
Case 2173 at diagnosis was a 44-year-old female with a clinical stage IV FL. By immunohistochemistry, the tumor cells were positive for CD20 and negative for CD3, CD43, CD45Ro, CD10, CD23, IgD, Bc1-2, Bc1-6, Cyclin D1, and p53. By¯ow cytometry, they showed IgM, and Igl expression. The karyotype by G-banding was 46, XX, t(1;14)(q21;q32),t(8;9)(q24;q13) [16] . The tumor progressed to a DLCL 34 months following the initial diagnosis. At this time, by immunohistochemistry, the tumor cells were positive for CD20, CD10, and negative for Bc1-2, CD3, CD43 and Cyclin D1. The karyotype, by G-banding, was 52-67,X,7X,71,t(1;14)(q21;q32),+der(14)(1;14) (q21;q32),del(1) (q12), + 2, add(4) (p11), + add(6) (q26),+i(6) (p10), +7, t(8;9) (q24;p13), 710, +11, 716, +17, +19x3, +22x4 [cp4]/46, XX [1] . Case 1389 was a 74-year-old female with histologic grade 1 FL, with histologic transformation to DLCL. By immunohistochemistry, the tumor cells were positive for CD20, CD10, Bc1-2 and p53, consistent with histologic transformation. By¯ow cytometry, they showed monoclonal Igl restriction, and were positive for CD19 and CD10. The karyotype, by G-banding, was 49,XX,del(X)(p11),dup(1) (q21q25),del(6)(q15q23), der(7)t(7;8)(q22;q13), +7, +8,del(10) (q22q24),+12,t(14,18)(q32;q21) [12] . A panel of 76 HNLs, each carrying a 1q21-23 cytogenetic aberration, was utilized for Southern blot analysis and RT ± PCR to assay for FCGR2 gene rearrangements and expression. These comprised 72 Bcell lymphomas and 4 T-cell lymphomas. The B-cell lymphomas included 31 cases of FL, of which 21 had the t(14;18)(q32;q21), 10 cases of low grade lymphomas other than FL, 30 cases of DLCL, and one case of Burkitt's lymphoma (BL). In addition, eight lymphoma cell lines, four with a t(14;18)(q32;q21) (OSI-Ly1, OSI-Ly3, OSI-Ly8, and OSI-Ly18) and four without the translocation (OSI-Ly7, OSI-Ly12, OSI-Ly13.2, and OSI-Ly17) kindly gifted by Mark Minden (Toronto) (Tweeddale et al., 1987) , also were used in the RT ± PCR analysis.
DNA probes
Probes used for Southern blotting analysis comprised the following: a 5.5-kbp BamHI ± HindIII fragment containing IGHJ (JH), a 7-kbp HindIII ± BamHI fragment containing IGHGI (Cg1), a 13-kbp HindIII fragment containing IGHAI (Ca1), a 719-bp fragment derived from PCR ampli®cation of 5' Sg (5'Sg) (Bergsagel et al., 1996) , and a 436-bp fragment derived from PCR ampli®cation of 3' Sg (3'Sg) (Bergsagel et al., 1996) . Probes used for¯uorescence in situ hybridization (FISH) analysis comprised the following: plasmid clones containing the JH and Ca1 probes mentioned above, a plasmid clone containing the 6-kbp BamHI ± HindIII region of IGHG4 (Cg4), and a phage clone (F1422) containing the JH to Cm region (Chaganti et al., 1998) . The PAC clones 288D9 containing BCL9, 35A12 containing MUCI, 408B18 containing BCL2, and 120H10 containing the region of 14q32 telomeric to the IGH locus were obtained from Genome Systems (St Louis, MO, USA). The YAC clone 748F9 containing IRTA1/IRTA2 was obtained from Research Genetics (Huntsville, AL, USA).
Fluorescence in situ hybridization
Non-chimeric YAC, BAC, PAC, phage, and plasmid clones were labeled with biotin-14-dUTP by nick translation and hybridized to tumor metaphases as previously described (Rao et al., 1993) . Hybridization signals and the corresponding bands were visualized with FITC-conjugated avidin following staining and counterstaining, respectively, with propidium iodide and 4,6'-diamindino-2-phenylindole.
Southern blot analysis and genomic cloning of tumor DNA Genomic DNA isolated from frozen tumor biopsies and normal human placenta was completely digested with BamHI, HindIII, and BglII respectively, electrophoresed on a 0.7% agarose gel, and transferred to nitrocellulose membranes (Oncor, Gaithersburg, MD, USA). For demonstration of co-migrating bands, the same ®lters were sequentially hybridized with the relevant IGH probes listed above, as previously described (Dyomin et al., 2000) . For cloning of rearranged bands, a genomic library of the tumor 2173 DNA was constructed following partial digestion with Sau3A according to conventional methods, and screened with the appropriate IGH gene probes.
Inverse PCR cloning of 5'Sg rearrangement
One microgram of tumor DNA was completely digested with HindIII and ligated at low concentration, followed by column puri®cation (Promega, Madison, WI, USA). DNA was ampli®ed by both primary and nested PCR using two primer sets derived from the 5' end of the HindIII fragment within the Sg region (primary set: 5'-CCAAGCCAACAGGGCAG-GACACA-3', 5'-TGGTCTCAGCCTCTCAATACCTGG-3'; nest set: 5'-GAGGAACATGACGGGATG-3'. 5'-CTCTCA-ATACCTGGGCCTCTCA-3'). PCR was performed in a 30 ml reaction at 948C for 1 min followed by 35 cycles at 948C for 1 min and at 688C for 6 min. The PCR product was puri®ed and run on a 1.5% agarose gel. The band corresponding to the size expected from Southern blot analysis was excised from the gel, and sub-cloned into a pGEM-T vector (Promega, Madison, WI, USA) for further propagation and sequence analysis.
Isolation, partial-subcloning, and sequencing of BAC clone(s)
A 360-bp novel sequence adjacent to the breakpoint was used as a probe to screen a human BAC library (Genome Systems, St. Louis, MO, USA). Two positive clones (342/P13 and 304/ N2) were isolated and mapped back to chromosome 1q21 by FISH of normal metaphases. For partial sequencing, DNA isolated from the BAC clone 342/P13 was digested with BamHI, separated on a 0.7% agarose gel, and all fragments below 20 kbp were excised, puri®ed, and sub-cloned into the pBluescript vector (Stratagene, La Jolla, CA, USA) for sequencing.
RT ± PCR analysis
Total RNA was isolated from tumor samples and cell lines using Trizol reagent (Life Technologies, Rockville, MD, USA) and ®rst-strand cDNA was synthesized by using the ®rst-strand RT ± PCR kit (Stratagene, La Jolla, CA, USA). Primers used for analysis of FCGR2A, FCGR2C and FCGR2B-b2 expression were as previously described (Metes et al., 1998) . Primer pairs for analysis of FCGR3B, and HSP70B expression comprised, respectively, 5'-GGTGTCTC-TGTGTCTTTCAG-3', 5'-GTCTCACCTTGAGTGATGGT-3'; and 5'-CTCGGTGTCGGTGAAGGCCA-3', 5'-TGCAG-GCCCCACGGGAGCTC-3'. cDNA quality was veri®ed by ampli®cation of b-actin.
